Teyi Pharmaceutical Hits Day High with 9.98% Surge in Stock Price

Teyi Pharmaceutical Group Co., Ltd. has experienced a significant uptick in its stock performance, gaining 9.98% on June 23, 2026. The stock reached an intraday high of CNY 8.82, marking a notable achievement for the small-cap company within the pharmaceuticals and biotechnology sector. In terms of performance metrics, Teyi's one-day gain stands in stark contrast to the China Shanghai Composite, which declined by 1.37% on the same day. Over the past week, Teyi has shown a positive trend with a 6.91% increase, while the broader market index saw a modest rise of 0.35%. However, the company's performance over the longer term reveals some challenges, with a year-to-date decline of 18.71% compared to a 3.46% gain in the Shanghai Composite. Despite these fluctuations, Teyi's financial indicators present a mixed picture. The company has a market capitalization of CNY 3,094 million and a price-to-earnings ratio of 41.00. Its return on equity stands at 4.11%, and it maintains a price-to-book ratio of 1.67. As Teyi navigates the complexities of the market, its recent performance highlights the ongoing dynamics within the pharmaceuticals and biotechnology industry.